ALBBY (ALBBY) Stock Price & Analysis
ALBBY (ALBBY) fell 10.26% to USD 8.75 as of June 10, 2026 at 02:35 UTC, according to Nexqual real-time market data.
ALBBY last closed at USD 9.75; the session ranged USD 8.75–8.75 on volume of 873 shares. Market capitalization is $7.05B, with a 52-week range of USD 8.75–19.45 (PNK). Source: Nexqual, June 10, 2026 at 02:35 UTC.
Key Statistics (as of June 10, 2026 at 02:35 UTC)
| Price | USD 8.75 |
|---|---|
| Change | ▼ 10.26% (down) |
| Previous Close | USD 9.75 |
| Open | USD 8.75 |
| Day Range | USD 8.75 – 8.75 |
| 52-Week Range | USD 8.75 – 19.45 |
| Volume | 873 shares |
| Market Cap | $7.05B |
| Exchange | PNK |
Technical Analysis (ALBBY)
Nexqual's technical model rates ALBBY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:35 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 6.53 (oversold) |
| vs SMA50 | Below (USD 10.98) |
| MACD | -0.69 (negative) |
Analyst Ratings (ALBBY)
Wall Street analysts rate ALBBY "None", per Nexqual as of June 10, 2026 at 02:35 UTC.
| Consensus Rating | None |
|---|
Earnings (ALBBY)
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Financials & Fundamentals (ALBBY)
| Total Revenue | $34.26B |
|---|---|
| Revenue Growth (YoY) | +7.60% |
| Gross Margin | +23.97% |
| Operating Margin | +1.69% |
| Profit Margin | +5.65% |
| ROE | +11.33% |
| Debt / Equity | 0.34 |
| Current Ratio | 3.03 |
| Total Cash | $10.17B |
| Total Debt | $59.76M |
| Free Cash Flow | $349.50M |
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Financial Health Score (ALBBY)
Nexqual rates ALBBY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:35 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 24%, operating 2% |
| Balance Sheet | Strong — $10.2B cash vs $60M debt, net cash position |
| Cash Flow | Mixed — FCF $350M, slim 1.0% margin |
| Efficiency | Mixed — ROE 11%, ROA 4.0% |
Ownership (ALBBY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 806.23M |
| Float | 293.26M |
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Leadership (ALBBY)
ALBBY is led by Difan Shen (age 47), Chairman & CEO, per Nexqual as of June 10, 2026 at 02:35 UTC.
| Chairman & CEO | Difan Shen (age 47) |
|---|---|
| CFO & Executive Director | Mengyue Sheng (age 43) |
| Chief Marketing Officer | Yin Rui |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALBHF | Alibaba Health Information Tech | USD 0.58 | ▲ 26.3% |
| SFOSF | SHANGHAI FOSUN PHARMACEUTICAL G | USD 2.6 | ▲ 19.54% |
| MTHRY | M3, Inc. | USD 5.01 | ▲ 3.32% |
| SHPMY | Shanghai Pharmaceuticals Holdin | USD 7.6 | ▲ 0% |
| SSMXY | Sysmex Corp. | USD 9.04 | ▼ 1.53% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:35 UTC. This page is informational and not investment advice.